Effect of 3 to 5 Years of Scheduled CEA ...

This episode of Healthy Dialogue explores the history and future of science funding in the US in light of recent changes, and proposed changes, from the federal government. Host Derek Angus, MD, MPH, speaks with former editor in chief of Science and a former director of the Natio ... Show More

In this episode of Healthy Dialogue, host Derek Angus, MD, MPH sits down with Dimitri Christakis, MD, MPH, to discuss whether social media use disorder is a real phenomenon, the mechanisms behind it, and its consequences for young people. Related Content: Social Media Use by Chil ... Show More

A growing number of young adults are being diagnosed with cancer, particularly colorectal cancer, but the underlying cause remains unclear. In this episode of Healthy Dialogue, Kimmie Ng, MD, MPH, and Ilana Richman, MD, MHS, discuss the increase in cases, potential causes, diagno ... Show More

In this episode, Dr Parveen Boora discusses colorectal cancer. Topics covered include: the epidemiology and natural history of colorectal cancer rationale of screening programs signs and symptoms of the disease history and physical exam findings leading to diagnosis staging and t ... Show More

Dr. Refky Nicola speaks with Dr. Perry Pickhardt about his study comparing CT colonography and multi-targeted stool DNA testing for colorectal cancer screening. They explore differences in sensitivity, specificity, cost-effectiveness, and strategies to optimize detection while mi ... Show More

<p>Dr. Manisha Bahl discusses the role of DCFPyL PET/CT in patients with initially diagnosed and biochemically recurrent prostate cancer with Dr. Gary Ulaner. </p> <p><a href= "https://doi.org/10.1148/radiol.220218">¹⁸F-DCFPyL PET/CT for Initially Diagnosed and Biochem ... Show More

Dr. Refky Nicola discusses Y-90 radioembolization for patients with metastatic colorectal cancer with Dr. Daniel Brown.  Survival and Toxicities after 90Y Transarterial Radioembolization of Metastatic Colorectal Cancer in the RESIN Registry. Emmons et al. Radiology 2022; 305:228– ... Show More

Interview with Kevin J. Contrera, MD, MPH, author of Neoadjuvant Therapy for Mucosal Head and Neck Squamous Cell Carcinoma: A Review From the American Head and Neck Society. Hosted by Paul C. Bryson, MD, MBA. Related Content: Neoadjuvant Therapy for Mucosal Head and Neck Squamous ... Show More

March is colon cancer awareness month so in today's episode, I discuss oncologic treatment options for colorectal cancer with Dr. Hardeep Phull. Dr. Phull is Medical Director of Oncology at Palomar Health and Clinical Instructor at the University of California San Diego. He gives ... Show More

Colorectal cancer is the fourth most common type of cancer in the UK, with over 40,000 new cases each year. The positive predictive value of Faecal immunochemical testing (FIT) far exceeds that of symptoms and makes FIT an important tool for triaging patients with symptoms sugges ... Show More

In this month's Talk Evidence, Helen Macdonald, The BMJ's research integrity editor, is joined again by Juan Franco, editor in chief of BMJ EBM, and Joe Ross, US research editor. They're straying beyond the pages of The BMJ, and discussing an NEJM paper about colonoscopy for co ... Show More

The incidence of early onset colorectal cancer (EOCRC) has been rising prompting the change in change in screening guidelines to 45 years of age for average risk patients. Join us for an in-depth discussion with guest speakers Dr. Andrea Cercek and Dr. Nancy You, where we provide ... Show More

Dr. Lauren Kim discusses results from the 20-year follow-up of the International Early Lung Cancer Action Program with Dr. Claudia Henschke, Dr. Rowena Yip, and Dr. David Yankelevitz. A 20-year Follow-up of the International Early Lung Cancer Action Program (I-ELCAP). Henschke an ... Show More